IP Library › Granted Patent US 7,067,127
Granted Patent B2
US 7,067,127 · App. 10/657,280 · Granted Jun 27, 2006

GIcNAc phosphotransferase of the lysosomal targeting pathway

Assignee: Genzyme Glycobiology Research Institute Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,127
App. No.
10/657,280
Granted
Jun 27, 2006
Kind
B2
Abstract

The present invention provides nucleotide and amino sequences of the lysosomal targeting pathway enzyme GlcNAc-phosphotransferase, methods of producing and methods of purifying this enzyme.

Claims (27)

1. An isolated N-acetylglucosamine-1-phosphotransferase comprising an α-subunit, a β-subunit and a γ-subunit, wherein the α-subunit comprises an amino acid sequence of SEQ ID NO:1 or an amino acid sequence having biological activity of an α-subunit of N-acetylglucosamine-1 -phosphotransferase and which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 165 to 2948 of SEQ ID NO:4,

the β-subunit comprises an amino acid sequence of SEQ ID NO:2 or an amino acid sequence having biological activity of a β-subunit of N-acetylglucosamine-1-phosphotransferase and which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 2949 to 3932 of SEQ ID NO:4, and

the γ-subunit comprises an amino acid sequence of SEQ ID NO:3 or an amino acid sequence having biological activity of a γ-subunit of N-acetylglucosamine-1-phosphotransferase and which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of SEQ ID NO:5,

wherein the stringent conditions comprise washing in 0.2×SSC and 0.1% SDS at 65° C.

2. The isolated N-acetylglucosamine-1-phosphotransferase of claim 1 , wherein the α-subunit comprises the amino acid sequence of SEQ ID NO:1.

3. The isolated N-acetylglucosamine-1-phosphotransferase of claim 1 , wherein the β-subunit comprises the amino acid sequence of SEQ ID NO:2.

4. The isolated N-acetylglucosamine-1-phosphotransferase of claim 1 , wherein the γ subunit comprises the amino acid sequence of SEQ ID NO:3.

5. A composition comprising the isolated N-acetylglucosamine-1-phosphotransferase of claim 1 and a carrier.

6. A composition comprising the isolated N-acetylglucosamine-1-phosphotransferase of claim 2 and a carrier.

7. A composition comprising the isolated N-acetylglucosamine-1-phosphotransferase of claim 3 and a carrier.

8. A composition comprising the isolated N-acetylglucosamine-1-phosphotransferase of claim 4 and a carrier.

9. An isolated polypeptide, which comprises an amino acid sequence which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 165 to 2948 of SEQ ID NO:4 and has the activity of a biologically active α-subunit of N-acetylglucosamine-1-phosphotransferase, wherein the stringent conditions comprise washing in 0.2×SSC and 0.1% SDS at 65° C.

10. The isolated polypeptide of claim 9 , which comprises SEQ ID NO:1.

11. A composition comprising the isolated polypeptide of claim 9 and a carrier.

12. A composition comprising the isolated polypeptide of claim 10 and a carrier.

13. An isolated polypeptide, which comprises an amino acid sequence which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 2949 to 3932 of SEQ ID NO:4 and has the activity of a biologically active β-subunit of N-acetylglucosamine-1 -phosphotransferase, wherein the stringent conditions comprise washing in 0.2×SSC and 0.1% SDS at 65° C.

14. The isolated polypeptide of claim 13 , which comprises SEQ ID NO:2.

15. A composition comprising the isolated polypeptide of claim 13 and a carrier.

16. A composition comprising the isolated polypeptide of claim 14 and a carrier.

17. An isolated polypeptide, which comprises an amino acid sequence which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of SEQ ID NO:5, and has the activity of a biologically active γ-subunit of N-acetylglucosamine-1-phosphotransferase, wherein the stringent conditions comprise washing in 0.2×SSC and 0.1% SDS at 65° C.

18. The isolated polypeptide of claim 17 , which comprises SEQ ID NO:3.

19. A composition comprising the isolated polypeptide of claim 17 and a carrier.

20. A composition comprising the isolated polypeptide of claim 18 and a carrier.

21. A composition comprising an isolated polypeptide which comprises an amino acid sequence which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 165 to 2948 of SEQ ID NO:4 and has the activity of a biologically active α-subunit of N-acetylglucosamine-1-phosphotransferase; and an isolated polypeptide which comprises an amino acid sequence which is encoded by an isolated nucleic acid which hybridizes under stringent conditions to the complement of nucleotides 2949 to 3932 of SEQ ID NO:4 and has the activity of a biologically active β-subunit of N-acetylglucosamine-1 -phosphotransferase,

wherein the stringent conditions comprise washing in 0.2×SSC and 0.1% SDS at 65° C.

22. The composition of claim 21 , which comprises SEQ ID NO:1 and SEQ ID NO:2.

23. The composition of claim 21 , further comprising a carrier.

Assignments (1)
MERGER Recorded Jan 24, 2006
From: GENZYME GLYCOBIOLOGY RESEARCH INSTITUTE, INC.
To: GENZYME CORPORATION
Reel/Frame 017207/0425 →
Continuity (3)
Division 0963606000 · Aug 10, 2000
Provisional Application 6015383100 · Sep 14, 1999
Related Publication 20050089869A1 · Apr 28, 2005